Imagyn sells impotence product line to reduce debt
This article was originally published in Clinica
Executive Summary
Imagyn Medical Technologies is to sell its impotence product line, which includes vacuum-assisted erection devices, to Timm Research Company for around $25.8 million, including a $9 million earnout. The company has also sold its adult reusable diaper division for an undisclosed amount. The proceeds from both transactions will be used to finance debt.